Immunohistochemical staining of dysferlin, ORO, and PAS in patients with suspected muscular dystrophy and metabolic myopathy are helpful for clinicians to exclude IMNM from muscular dystrophy and metabolic myopathy [25, 32, 33]. Here, DYSF is linked to metabolic myopathy.